Skip to Main Content

Resource Type

News

Blog

January 12, 2023

38 ARA Radiologists Make the Austin Monthly 2023 Top Docs List

ARA radiologists are fully invested in the patients and medical providers of Central Texas, bringing expertise, service, and caring to work...

Blog

October 17, 2022

ARA breast radiologist goes all pink to emphasize importance of mammography

It’s Breast Cancer Awareness Month, and many are working to bring attention to breast cancer and the importance of screening with...

Blog

September 13, 2022

ARA Theranostics Center Certified as a Center of Excellence

Recently designated a Radiopharmaceutical Therapy Center of Excellence, the ARA Theranostics Center brings expertise in molecular radiology to patients throughout Central...

Blog

July 22, 2022

ARA welcomes first class of Dell Med diagnostic radiology residents

In addition to their work in ARA Diagnostic Imaging centers and local hospitals, many ARA radiologists have thriving academic lives. For...

Blog

July 18, 2022

ARA Administers First Prostate Cancer Treatment with LU-177 PSMA (Pluvicto)

Thursday, July 14, was a notable day at ARA. The team at the ARA Theranostics Center administered the first dose in...

Blog

December 16, 2021

PET/CT with Pylarify available at ARA

A PARADIGM SHIFT IN IDENTIFYING PROSTATE CANCER ARA is excited to offer a revolutionary radiotracer for the identification of prostate cancer. PET/CT...

Blog

June 15, 2021

ARA to offer prostate cancer imaging agent Pylarify pending CMS approval

FDA APPROVES PYLARIFY AS FIRST AND ONLY COMMERCIALLY AVAILABLE PSMA PET IMAGING AGENT FOR PROSTATE CANCER On May 27, 2021, Lantheus...

Blog

June 15, 2021

CMS approval expected for Amyvid after FDA approval of aducanumab treatment for Alzheimer’s Disease

AMYVID FOR ALZHEIMER’S DIAGNOSIS In 2012, the FDA approved Amyvid (florbetapir F 18), a radiopharmaceutical for use in PET imaging of...

Back to Top
Technical Assistance